Track topics on Twitter Track topics that are important to you
P.O. Box 3206
Phone: 972 4 999-0478/9
Fax: 972 4 999-0480
Fulcrum’s use of bioinformatics in small molecule drug discovery led Foresite to lead its $80 million series B round.
Proceeds from the financing will be used to advance Fulcrum’s lead program in facioscapulohumeral muscular dystrophy (FSHD) into clinical testing, and to progress its pipeline of therapeutics for T...
Fulcrum Therapeutics, a Cambridge, MA, startup run by the former CEO of Epizyme, has closed an $80 million Series B round that lays the groundwork for a likely IPO next year, its CEO says. The new fun...
Fulcrum Therapeutics, based in Cambridge, Massachusetts, closed on an $80 million Series B financing.
Fulcrum Therapeutics Inc. (small molecules for genetic diseases) raised $80mm in its Series B financing led by Foresite Capital, which adds a board member and was joined by Fidelity, 6 Dimensions Capi...
Zealand Pharma has sold its future royalty streams and potential commercial milestones for Soliqua® 100/33/Suliqua® and Lyxumia®/Adlyxin® to Royalty Pharma...Read More... The post Deals this week:...
Fulcrum Therapeutics, a company focused on discovering and developing small molecule therapies to unlock gene control and treat serious genetic diseases, today announced th...
To compare the characteristics of Cobb angle distribution of the main thoracic curve (MTC) in patients with Lenke 1 adolescent idiopathic scoliosis (AIS) and differences in fulcrum-bending flexibility...
A rotational mechanism of slipped capital femoral epiphysis (SCFE) in which the epiphyseal tubercle acts as a fulcrum has been recently described. However, there is limited radiographic evidence suppo...
Robotic minimally invasive surgery has been rapidly adopted for a wide variety of surgical procedures in adult patients across a broad spectrum of surgical specialties. This has occurred d...
Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients and their families by transforming gene regulation in disease. Fulcrum...
Fulcrum Pharma Developments works with biotech and pharmaceutical companies to mitigate the risks associated with drug development. Fulcrum’s development specialists work as an extension of your dev...
Established in January 2001 and headquartered in Rehovot, Israel, Fulcrum SP Ltd. is a biotechnological company focused on the research and application of high-performance stable proteins. The company...
Fulcrum Pharma is an independent public company that is the first to offer global virtual drug development and strategic outsourcing services to the pharmaceutical and biotechnology industries. Fulcru...
We have published hundreds of Fulcrum SP Ltd. news stories on BioPortfolio along with dozens of Fulcrum SP Ltd. Clinical Trials and PubMed Articles about Fulcrum SP Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Fulcrum SP Ltd. Companies in our database. You can also find out about relevant Fulcrum SP Ltd. Drugs and Medications on this site too.
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...